Monkeypox is an exotic infectious disease caused by the monkeypox virus. The disease was first identified in laboratory monkeys, thus earning its name, but in its natural state, it seems to infect rodents more than primates. In humans, a fever, headache, muscle pains, swollen lymph nodes, and fatigue are the first symptoms. After this, a rash forms with blisters and crusts. Symptoms typically appear 7 to 14 days after exposure. In most cases, symptoms last 2 to 4 weeks. Children, pregnant women, and people with suppressed immune systems are at greater risk of severe cases.
Human Monkeypox – Epidemiology, Clinical Characteristics, Diagnosis, and Prevention
The human monkeypox virus, which belongs to the genus Orthopoxvirus of the family Poxviridae, is a DNA virus.
In a new study, researchers developed two monkeypox (MPX) virus (MPXV) quadrivalent messenger ribonucleic acid (mRNA) vaccines, mRNA-A-lipid nanoparticle (LNP) and mRNA-B-LNP.
A modeling study to explore optimal allocation of vaccines against monkeypox virus (MPXV) provides a road map for public health to maximize the impact of a limited supply of vaccines.
Researchers determined whether neutralizing antibody levels were predictive of the efficacy of fractional vaccine doses against SARS-CoV-2 infection.
Researchers investigated whether undetected human monkeypox virus transmission occurred before Rotterdam and Amsterdam's first documented monkeypox cases.
In a recent study posted to the bioRxiv* preprint server, researchers in China demonstrated the efficacy of three messenger ribonucleic acid (mRNA) technology-based Monkeypox virus (MPXV) vaccines in combating a lethal Vaccinia virus (VACV) challenge in mice models.
People in many countries are contracting monkeypox, even though they have not travelled to any regions where the virus is mainly circulating.
A recent study described the clinical and epidemiologic features of infection with monkeypox virus (MPXV) in cisgender (cis) and transgender (trans) females and non-binary individuals.
Researchers demonstrated the efficacy of two World Health Organization (WHO)‒recommended alcohol-based hand rub solutions to inactivate the monkeypox virus (MPXV).
The World Health Organization (WHO) recently conducted a virtual press conference on global health emergencies on November 16, 2022. Margaret Harris hosted the conference at WHO Headquarters in Geneva. In addition, a broad panel of technical experts was present online and offline for discussion.
When Elko County commissioners rejected a $500,000 grant from the Centers for Disease Control and Prevention that could have helped the county create a health department or health district, Kayla Hopkins pleaded with them to reconsider.
Researchers illustrated the baseline trajectory of the monkeypox virus (MPXV) epidemic anticipated under the sole effect of infection-derived or herd immunity.
Researchers validated monkeypox virus (MPXV) quantitative polymerase chain reaction (qPCR) assays.
Researchers evaluated dose-sparing strategies for monkeypox (MPX) vaccination using mathematical modeling.
In a recent study published in the journal Clinical Infectious Diseases, researchers evaluated the accuracy of patient-collected samples in diagnosing monkeypox virus infections.
In a recent study posted to the medRxiv* preprint server, researchers investigated the incidence of cardiac AESIs (adverse events of special interest) among Kaiser Permanente Northwest (KPNW) members who had received JYNNEOS vaccinations against the monkeypox (MPX) virus.
A recent study published in the Morbidity and Mortality Weekly Report described the epidemiologic characteristics of the monkeypox (MPX) outbreak in the United States (US).
As covid-19 raged, roughly 4,000 highly skilled epidemiologists, communication specialists, and public health nurses were hired by a nonprofit tied to the Centers for Disease Control and Prevention to plug the holes at battered public health departments on the front lines.
A recent study presents the first known case of myocarditis as a complication of monkeypox virus infection.
Researchers revisit lessons learned from the HIV pandemic in response to COVID-19.
Recent infection with monkeypox virus can initially present with very few pronounced clinical symptoms and lacking signs of infection, and only few skin vesicles may be visible.